The Interaction Between Resting Metabolic Rate, Physical Activity and Thyroid Hormone in Females
Launched by SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY ,CHINESE ACADEMY OF SCIENCES · Apr 17, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how resting metabolic rate (RMR), which is the energy your body uses when at rest, interacts with physical activity and thyroid hormones in women. Thyroid hormones are important because they help control many body functions, including metabolism. The researchers want to understand how differences in thyroid hormone levels can affect how active women are in their daily lives.
To take part in this study, you need to be a woman aged 18 or older with a body mass index (BMI) of 18.5 or higher. However, some people will not be able to join, such as those who have recently tried to change their weight significantly, have certain medical conditions, or are pregnant or breastfeeding. If eligible, participants can expect to provide information about their physical activity and may undergo tests to measure their metabolic rate and thyroid hormone levels. It's important to know that the study is not currently recruiting participants, but it aims to help us better understand the relationship between thyroid health and physical activity in women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female age ≥18;
- • BMI≥18.5
- Exclusion Criteria:
- • Intended weight change exceeding 2kg within the past three months;
- • Having any special medical diets or having eating disorders;
- • Pregnant women or breastfeeding women;
- • People who have metal implants in their bodies;
- • Patients with metabolic diseases, infectious diseases, and genetic disorders such as hypothyroidism, and hyperthyroidism;
- • Patients with a personal or family history of medullary thyroid carcinoma (MTC), or patients with rare type 2 multiple endocrine tumor syndrome (MEN2); People with a fear of needles (Trypanophobia), claustrophobia; People who are fear of blood (Hemophobia) or pathological hypotension;
About Shenzhen Institutes Of Advanced Technology ,Chinese Academy Of Sciences
The Shenzhen Institutes of Advanced Technology (SIAT), part of the Chinese Academy of Sciences, is a leading research institution dedicated to advancing scientific knowledge and technology across various fields, including biomedical research. SIAT is committed to fostering innovation through interdisciplinary collaboration and state-of-the-art facilities, focusing on the translation of research into practical applications. With a strong emphasis on clinical trials and regulatory compliance, SIAT aims to contribute to the global healthcare landscape by developing novel therapies and solutions that address pressing medical challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
John R Speakman, PhD
Study Chair
Shenzhen Institute of Advanced Technology, CAS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported